Loading…
Reported covered position: Vice President, Government Relations and Advocacy
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
HELP Copays Act (S. 864): Importance of ensuring copay assistance works on behalf of those living with chronic diseases and disabilities Safe Step Act (no bill number): Common sense guardrails around the practice of step therapy.
HELP Copays Act (S. 864): Importance of ensuring copay assistance works on behalf of those living with chronic diseases and disabilities Safe Step Act (no bill number): Common sense guardrails around the practice of step therapy.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL PSORIASIS FOUNDATION via NATIONAL PSORIASIS FOUNDATION
2026 · first_quarter · Q1
Step therapy reform, copay assistance reform, health insurance reform
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL PSORIASIS FOUNDATION via NATIONAL PSORIASIS FOUNDATION
2025 · fourth_quarter · Q4
Source: Senate LDA
HELP Copays Act (S. 864): Importance of ensuring copay assistance works on behalf of those living with chronic diseases and disabilities Safe Step Act (no bill number): Common sense guardrails around the practice of step therapy.
HELP Copays Act (S. 864): Importance of ensuring copay assistance works on behalf of those living with chronic diseases and disabilities Safe Step Act (no bill number): Common sense guardrails around the practice of step therapy.
Federal Step Therapy Reform: Safe Step Act (HR 2163/S 464). The bill reforms step therapy insurance protocols to ensure patients and providers have access to a clear exemption process. It establishes a patient and provider friendly step therapy guidelines in ERISA regulated health insurance plans. Federal copay accumulator reform: HELP Copays Act (HR 5801). The bill ensures that all copays count by requiring insurers to count all third-party copay assistance towards a patients deductible or out-of-pocket maximum.
Federal Step Therapy Reform: Safe Step Act (HR 2163/S 464). The bill reforms step therapy insurance protocols to ensure patients and providers have access to a clear exemption process. It establishes a patient and provider friendly step therapy guidelines in ERISA regulated health insurance plans. Federal copay accumulator reform: HELP Copays Act (HR 5801). The bill ensures that all copays count by requiring insurers to count all third-party copay assistance towards a patients deductible or out-of-pocket maximum.
Federal Step Therapy Reform: Safe Step Act (HR 2163/S 464). The bill reforms step therapy insurance protocols to ensure patients and providers have access to a clear exemption process. It establishes a patient and provider friendly step therapy guidelines in ERISA regulated health insurance plans. Federal copay accumulator reform: HELP Copays Act (HR 5801). The bill ensures that all copays count by requiring insurers to count all third-party copay assistance towards a patients deductible or out-of-pocket maximum.
Federal Step Therapy Reform: Safe Step Act (HR 2163/S 464). The bill reforms step therapy insurance protocols to ensure patients and providers have access to a clear exemption process. It establishes a patient and provider friendly step therapy guidelines in ERISA regulated health insurance plans. Federal copay accumulator reform: HELP Copays Act (HR 5801). The bill ensures that all copays count by requiring insurers to count all third-party copay assistance towards a patients deductible or out-of-pocket maximum.
Federal Step Therapy Reform: Safe Step Act (HR 2163/S 464). The bill reforms step therapy insurance protocols to ensure patients and providers have access to a clear exemption process. It establishes a patient and provider friendly step therapy guidelines in ERISA regulated health insurance plans. Federal copay accumulator reform: HELP Copays Act (HR 5801). The bill ensures that all copays count by requiring insurers to count all third-party copay assistance towards a patients deductible or out-of-pocket maximum.
Federal Step Therapy Reform: Safe Step Act (HR 2163/S 464). The bill reforms step therapy insurance protocols to ensure patients and providers have access to a clear exemption process. It establishes a patient and provider friendly step therapy guidelines in ERISA regulated health insurance plans. Federal copay accumulator reform: HELP Copays Act (HR 5801). The bill ensures that all copays count by requiring insurers to count all third-party copay assistance towards a patients deductible or out-of-pocket maximum.
Federal Step Therapy Reform: Safe Step Act (HR 2163/S 464). The bill reforms step therapy insurance protocols to ensure patients and providers have access to a clear exemption process. It establishes a patient and provider friendly step therapy guidelines in ERISA regulated health insurance plans. Federal copay accumulator reform: HELP Copays Act (HR 5801). The bill ensures that all copays count by requiring insurers to count all third-party copay assistance towards a patients deductible or out-of-pocket maximum.
Federal Step Therapy Reform: Safe Step Act (HR 2163/S 464). The bill reforms step therapy insurance protocols to ensure patients and providers have access to a clear exemption process. It establishes a patient and provider friendly step therapy guidelines in ERISA regulated health insurance plans. Federal copay accumulator reform: HELP Copays Act (HR 5801). The bill ensures that all copays count by requiring insurers to count all third-party copay assistance towards a patients deductible or out-of-pocket maximum.
Federal Step Therapy Reform: Safe Step Act (HR 2163/S 464). The bill reforms step therapy insurance protocols to ensure patients and providers have access to a clear exemption process. It establishes a patient and provider friendly step therapy guidelines in ERISA regulated health insurance plans. Federal copay accumulator reform: HELP Copays Act (HR 5801). The bill ensures that all copays count by requiring insurers to count all third-party copay assistance towards a patients deductible or out-of-pocket maximum.
Federal Step Therapy Reform: Safe Step Act (HR 2163/S 464). The bill reforms step therapy insurance protocols to ensure patients and providers have access to a clear exemption process. It establishes a patient and provider friendly step therapy guidelines in ERISA regulated health insurance plans. Federal copay accumulator reform: HELP Copays Act (HR 5801). The bill ensures that all copays count by requiring insurers to count all third-party copay assistance towards a patients deductible or out-of-pocket maximum.
Federal Step Therapy Reform: Safe Step Act (HR 2163/S 464). The bill reforms step therapy insurance protocols to ensure patients and providers have access to a clear exemption process. It establishes a patient and provider friendly step therapy guidelines in ERISA regulated health insurance plans. Federal copay accumulator reform: HELP Copays Act (HR 5801). The bill ensures that all copays count by requiring insurers to count all third-party copay assistance towards a patients deductible or out-of-pocket maximum.
Federal Step Therapy Reform: Safe Step Act (HR 2163/S 464). The bill reforms step therapy insurance protocols to ensure patients and providers have access to a clear exemption process. It establishes a patient and provider friendly step therapy guidelines in ERISA regulated health insurance plans. Federal copay accumulator reform: HELP Copays Act (HR 5801). The bill ensures that all copays count by requiring insurers to count all third-party copay assistance towards a patients deductible or out-of-pocket maximum.
Federal Step Therapy Reform: Safe Step Act (HR 2163/S 464). The bill reforms step therapy insurance protocols to ensure patients and providers have access to a clear exemption process. It establishes a patient and provider friendly step therapy guidelines in ERISA regulated health insurance plans. Federal copay accumulator reform: HELP Copays Act (HR 5801). The bill ensures that all copays count by requiring insurers to count all third-party copay assistance towards a patients deductible or out-of-pocket maximum.
Federal Step Therapy Reform: Safe Step Act (HR 2163/S 464). The bill reforms step therapy insurance protocols to ensure patients and providers have access to a clear exemption process. It establishes a patient and provider friendly step therapy guidelines in ERISA regulated health insurance plans. Federal copay accumulator reform: HELP Copays Act (HR 5801). The bill ensures that all copays count by requiring insurers to count all third-party copay assistance towards a patients deductible or out-of-pocket maximum.
Federal Step Therapy Reform: Safe Step Act (HR 2163/S 464). The bill reforms step therapy insurance protocols to ensure patients and providers have access to a clear exemption process. It establishes a patient and provider friendly step therapy guidelines in ERISA regulated health insurance plans. Federal copay accumulator reform: HELP Copays Act (HR 5801). The bill ensures that all copays count by requiring insurers to count all third-party copay assistance towards a patients deductible or out-of-pocket maximum.
HELP Copays Act (S. 864): Importance of ensuring copay assistance works on behalf of those living with chronic diseases and disabilities Safe Step Act (no bill number): Common sense guardrails around the practice of step therapy.
Communicate the importance of the Medicare and Medicaid program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL PSORIASIS FOUNDATION via NATIONAL PSORIASIS FOUNDATION
2025 · third_quarter · Q3
HELP Copays Act (S. 864): Importance of ensuring copay assistance works on behalf of those living with chronic diseases and disabilities Safe Step Act (no bill number): Common sense guardrails around the practice of step therapy.
Communicate the importance of the Medicaid program as Congress deliberated on reconciliation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL PSORIASIS FOUNDATION via NATIONAL PSORIASIS FOUNDATION
2025 · second_quarter · Q2
HELP Copays Act (S. 864): Importance of ensuring copay assistance works on behalf of those living with chronic diseases and disabilities Safe Step Act (no bill number): Common sense guardrails around the practice of step therapy.
Communicate the importance of the Medicaid program as Congress deliberated on reconciliation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL PSORIASIS FOUNDATION via NATIONAL PSORIASIS FOUNDATION
2025 · first_quarter · Q1
HELP Copays Act (S. 864): Importance of ensuring copay assistance works on behalf of those living with chronic diseases and disabilities Safe Step Act (no bill number): Common sense guardrails around the practice of step therapy.
Communicate the importance of the Medicaid program as Congress deliberated on reconciliation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL PSORIASIS FOUNDATION via NATIONAL PSORIASIS FOUNDATION
2024 · fourth_quarter · Q4
CDC chronic disease education and awareness program
Safe step act, help copays act, chronic disease education and awareness program at CDC, PBM reform.
Inflation Reduction Act and Part D out of pocket cap.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL PSORIASIS FOUNDATION via NATIONAL PSORIASIS FOUNDATION
2023 · fourth_quarter · Q4
Inflation Reduction Act and Part D out of pocket cap.
CDC chronic disease education and awareness program - appropriations!
Safe step act, help copays act, chronic disease education and awareness program at CDC.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL PSORIASIS FOUNDATION via NATIONAL PSORIASIS FOUNDATION
2023 · third_quarter · Q3
Inflation Reduction Act and Part D out of pocket cap.
Safe step act, help copays act, chronic disease education and awareness program at CDC.
CDC chronic disease education and awareness program - appropriations!
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL PSORIASIS FOUNDATION via NATIONAL PSORIASIS FOUNDATION
2023 · second_quarter · Q2
Safe step act, help copays act, chronic disease education and awareness program at CDC.
Inflation Reduction Act and Part D out of pocket cap.
CDC chronic disease education and awareness program - appropriations!
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL PSORIASIS FOUNDATION via NATIONAL PSORIASIS FOUNDATION
2023 · first_quarter · Q1
CDC chronic disease education and awareness program - appropriations!
Safe step act, help copays act, chronic disease education and awareness program at CDC.
Inflation Reduction Act and Part D out of pocket cap.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL PSORIASIS FOUNDATION via NATIONAL PSORIASIS FOUNDATION
2022 · fourth_quarter · Q4
Pending legislation and regulatory rules impacting the space, including but not limited to ACA marketplace plans, out-of-pocket spending, Medicare Part D reform, and telehealth flexibility/permanence.
Federal Step Therapy Reform: Safe Step Act (HR 2163/S 464). The bill reforms step therapy insurance protocols to ensure patients and providers have access to a clear exemption process. It establishes a patient and provider friendly step therapy guidelines in ERISA regulated health insurance plans. Federal copay accumulator reform: HELP Copays Act (HR 5801). The bill ensures that all copays count by requiring insurers to count all third-party copay assistance towards a patients deductible or out-of-pocket maximum.
NATIONAL PSORIASIS FOUNDATION via NATIONAL PSORIASIS FOUNDATION
2022 · third_quarter · Q3
Federal Step Therapy Reform: Safe Step Act (HR 2163/S 464). The bill reforms step therapy insurance protocols to ensure patients and providers have access to a clear exemption process. It establishes a patient and provider friendly step therapy guidelines in ERISA regulated health insurance plans. Federal copay accumulator reform: HELP Copays Act (HR 5801). The bill ensures that all copays count by requiring insurers to count all third-party copay assistance towards a patients deductible or out-of-pocket maximum.
FY23 Appropriations for Psoriatic Disease. $6 million of the Chronic Disease Education and Awareness Program (CDEA) at the Centers for Disease Control and Prevention (CDC). And to allocate funding in the Fiscal Year 2023 Labor, Health and Human Services, Education and Related Agencies (LHHS) Appropriations bill to implement a public health agenda for psoriasis and psoriatic arthritis at the Centers for Disease Control and Prevention (CDC). Within this funding, the CDC would: Better understand linkages between psoriasis and psoriatic arthritis and other multiple chronic conditions, to develop a focused public health applied research agenda for psoriatic disease.
NATIONAL PSORIASIS FOUNDATION via NATIONAL PSORIASIS FOUNDATION
2022 · second_quarter · Q2
Federal Step Therapy Reform: Safe Step Act (HR 2163/S 464). The bill reforms step therapy insurance protocols to ensure patients and providers have access to a clear exemption process. It establishes a patient and provider friendly step therapy guidelines in ERISA regulated health insurance plans. Federal copay accumulator reform: HELP Copays Act (HR 5801). The bill ensures that all copays count by requiring insurers to count all third-party copay assistance towards a patients deductible or out-of-pocket maximum.
Pending legislation and regulatory rules impacting the space, including but not limited to ACA marketplace plans, out-of-pocket spending, Medicare Part D reform, and telehealth flexibility/permanence.
NATIONAL PSORIASIS FOUNDATION via NATIONAL PSORIASIS FOUNDATION
2022 · first_quarter · 1A
Federal Step Therapy Reform: Safe Step Act (HR 2163/S 464). The bill reforms step therapy insurance protocols to ensure patients and providers have access to a clear exemption process. It establishes a patient and provider friendly step therapy guidelines in ERISA regulated health insurance plans. Federal copay accumulator reform: HELP Copays Act (HR 5801). The bill ensures that all copays count by requiring insurers to count all third-party copay assistance towards a patients deductible or out-of-pocket maximum.
FY23 Appropriations for Psoriatic Disease. $6 million of the Chronic Disease Education and Awareness Program (CDEA) at the Centers for Disease Control and Prevention (CDC). And to allocate funding in the Fiscal Year 2023 Labor, Health and Human Services, Education and Related Agencies (LHHS) Appropriations bill to implement a public health agenda for psoriasis and psoriatic arthritis at the Centers for Disease Control and Prevention (CDC). Within this funding, the CDC would: Better understand linkages between psoriasis and psoriatic arthritis and other multiple chronic conditions, to develop a focused public health applied research agenda for psoriatic disease.
NATIONAL PSORIASIS FOUNDATION via NATIONAL PSORIASIS FOUNDATION
2022 · first_quarter · Q1
Pending legislation and regulatory rules impacting the space, including but not limited to ACA marketplace plans, out-of-pocket spending, Medicare Part D reform, and telehealth flexibility/permanence.
Federal Step Therapy Reform: Safe Step Act (HR 2163/S 464). The bill reforms step therapy insurance protocols to ensure patients and providers have access to a clear exemption process. It establishes a patient and provider friendly step therapy guidelines in ERISA regulated health insurance plans. Federal copay accumulator reform: HELP Copays Act (HR 5801). The bill ensures that all copays count by requiring insurers to count all third-party copay assistance towards a patients deductible or out-of-pocket maximum.
NATIONAL PSORIASIS FOUNDATION via NATIONAL PSORIASIS FOUNDATION
2022 · first_quarter · RA
Appropriations; affordable care act; FDA; CMS; legislation related to utilization management (step therapy), copay accumulators
Appropriations; affordable care act; FDA; CMS; legislation related to utilization management (step therapy), copay accumulators
Appropriations; affordable care act; FDA; CMS; legislation related to utilization management (step therapy), copay accumulators
FY23 Appropriations for Psoriatic Disease. $6 million of the Chronic Disease Education and Awareness Program (CDEA) at the Centers for Disease Control and Prevention (CDC). And to allocate funding in the Fiscal Year 2023 Labor, Health and Human Services, Education and Related Agencies (LHHS) Appropriations bill to implement a public health agenda for psoriasis and psoriatic arthritis at the Centers for Disease Control and Prevention (CDC). Within this funding, the CDC would: Better understand linkages between psoriasis and psoriatic arthritis and other multiple chronic conditions, to develop a focused public health applied research agenda for psoriatic disease.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Pending legislation and regulatory rules impacting the space, including but not limited to ACA marketplace plans, out-of-pocket spending, Medicare Part D reform, and telehealth flexibility/permanence.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FY23 Appropriations for Psoriatic Disease. $6 million of the Chronic Disease Education and Awareness Program (CDEA) at the Centers for Disease Control and Prevention (CDC). And to allocate funding in the Fiscal Year 2023 Labor, Health and Human Services, Education and Related Agencies (LHHS) Appropriations bill to implement a public health agenda for psoriasis and psoriatic arthritis at the Centers for Disease Control and Prevention (CDC). Within this funding, the CDC would: Better understand linkages between psoriasis and psoriatic arthritis and other multiple chronic conditions, to develop a focused public health applied research agenda for psoriatic disease.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Pending legislation and regulatory rules impacting the space, including but not limited to ACA marketplace plans, out-of-pocket spending, Medicare Part D reform, and telehealth flexibility/permanence.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FY23 Appropriations for Psoriatic Disease. $6 million of the Chronic Disease Education and Awareness Program (CDEA) at the Centers for Disease Control and Prevention (CDC). And to allocate funding in the Fiscal Year 2023 Labor, Health and Human Services, Education and Related Agencies (LHHS) Appropriations bill to implement a public health agenda for psoriasis and psoriatic arthritis at the Centers for Disease Control and Prevention (CDC). Within this funding, the CDC would: Better understand linkages between psoriasis and psoriatic arthritis and other multiple chronic conditions, to develop a focused public health applied research agenda for psoriatic disease.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE